DNA Ploidy

Immunopath

Interpath




Diagnostic and prognistic information for Cancer

Quantative IHC

Remote viewing for whole slide images

DNA Ploidy is becoming an accepted prognostic marker. The DNA Ploidy test alone can be used to obtain prognostic information to determine treatment decisions in prostatic, urinary bladder, ovarian, endometrial and renal cell carcinoma among others. The test can also be an additive prognostic marker, Learn More.

Human review of Immunohistochemistry stains is time consuming and laborious. Counting cells or guessing the percentage stain of a slide is not something that anyone enjoys, Learn More.

Whole slide imaging systems are an important tool in pathology there is acceptance that these images can be used for diagnostic use and research. Our internet based case review system links the virtual microscope aspect of the imaged slides, other clinical information and associated images in a single location, Learn More.

Other Developments
 
Other developments in progress include: Live Cell tracking, linking of Whole Slide Images (WSI) to traditional microscopes and a Tissue Micro Array (TMA) scoring system.
 
DNA Ploidy - Diagnostic and prognostic information for cancer DNA Ploidy is becoming an accepted prognostic marker. The DNA Ploidy test alone can be used to obtain prognostic information to determine treatment decisions in prostatic, urinary bladder, ovarian, endometrial and renal cell carcinoma among others. The test can also be an additive prognostic marker.